On Monday, Fractyl Health Inc. (NASDAQ: GUTS) was 16.46% up from the session before settling in for the closing price of $2.37. A 52-week range for GUTS has been $1.74 – $14.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 96.46%. With a float of $19.88 million, this company’s outstanding shares have now reached $47.93 million.
In terms of profitability, gross margin is -267.23%, operating margin of -59984.03%, and the pretax margin is -46620.17%.
Fractyl Health Inc. (GUTS) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Fractyl Health Inc. stocks. The insider ownership of Fractyl Health Inc. is 58.52%, while institutional ownership is 30.11%. The most recent insider transaction that took place on Sep 12 ’24, was worth 188,474. In this transaction President, Chief Product Off. of this company sold 65,000 shares at a rate of $2.90, taking the stock ownership to the 30,484 shares. Before that another transaction happened on Sep 12 ’24, when Company’s Officer proposed sale 65,000 for $2.85, making the entire transaction worth $185,213.
Fractyl Health Inc. (GUTS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.52 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 96.46% per share during the next fiscal year.
Fractyl Health Inc. (NASDAQ: GUTS) Trading Performance Indicators
You can see what Fractyl Health Inc. (GUTS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1102.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.10, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -2.48 in one year’s time.
Technical Analysis of Fractyl Health Inc. (GUTS)
The latest stats from [Fractyl Health Inc., GUTS] show that its last 5-days average volume of 0.5 million was superior to 0.31 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 39.29%. Additionally, its Average True Range was 0.26.
During the past 100 days, Fractyl Health Inc.’s (GUTS) raw stochastic average was set at 19.21%, which indicates a significant decrease from 52.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.43% in the past 14 days, which was lower than the 100.40% volatility it showed in the past 100 days.
Now, the first resistance to watch is $3.14. This is followed by the second major resistance level at $3.53. The third major resistance level sits at $3.83. If the price goes on to break the first support level at $2.45, it is likely to go to the next support level at $2.15. The third support level lies at $1.76 if the price breaches the second support level.
Fractyl Health Inc. (NASDAQ: GUTS) Key Stats
There are 47,897K outstanding shares of the company, which has a market capitalization of 132.29 million. As of now, sales total 120 K while income totals -77,090 K. Its latest quarter income was 40 K while its last quarter net income were -17,230 K.
